https://legacy.arianapharma.com/in-the-news/ https://legacy.arianapharma.com/ariana-pharma-and-usil-therapeutics-announce-ai-powered-collaboration-to-advance-development-of-ut-241-in-acute-radiation-syndrome/ 2026-07-13T15:11:06+00:00 https://legacy.arianapharma.com/a-new-chapter-ariana-pharma-appoints-thomas-turcat-as-chief-executive-officer/ 2026-07-07T08:15:46+00:00 https://legacy.arianapharma.com/news-text-ariana-pharmaceuticals-publishes-new-study-on-ai-driven-discovery-of-genomic-biomarkers-for-liver-toxicity-risk/ 2026-04-07T07:18:31+00:00 https://legacy.arianapharma.com/ariana-reaffirms-its-position-on-drug-development-and-publishes-its-new-manifesto/ 2025-11-10T09:02:25+00:00 https://legacy.arianapharma.com/ariana-pharma-strengthens-sab-with-appointment-of-world-leading-neurologist-jacques-touchon/ 2025-06-17T08:39:58+00:00 https://legacy.arianapharma.com/ariana-pharma-continues-to-bolster-scientific-advisory-board-by-adding-world-leading-oncologist/ 2025-06-17T08:38:25+00:00 https://legacy.arianapharma.com/ai-collaboration-in-cell-therapy/ 2025-06-17T08:34:59+00:00 https://legacy.arianapharma.com/ariana-pharma-announces-important-artificial-intelligence-ai-collaboration-in-precision-oncology-to-accelerate-a-first-in-class-antibody-blocking-lipid-metabolism-for-the-treatment-of-advanced-cance/ 2025-06-17T08:32:07+00:00 https://legacy.arianapharma.com/ariana-is-20-weve-come-a-long-way/ 2025-06-17T08:27:27+00:00 https://legacy.arianapharma.com/corpusanalytix-and-ariana-pharmaannounce-collaborative-alliance-toaccelerate-ai-driven-drugdevelopment/ 2025-06-17T08:23:52+00:00 https://legacy.arianapharma.com/1-new-nomination/ 2024-11-27T09:27:45+00:00 https://legacy.arianapharma.com/passing-of-dr-mohammad-afshar-founder-of-arianapharma/ 2024-10-07T12:28:09+00:00 https://legacy.arianapharma.com/colon-cancer-and-combination-therapy-ariana-to-present-data-at-aacr-2019-using-its-ai-technology-and-pdx-mouse-model-simulated-clinical-trial/ 2024-05-06T12:30:34+00:00 https://legacy.arianapharma.com/ariana-pharma-helps-valiseek-demonstrate-efficacy-of-its-lung-cancer-therapy-in-phase-2-clinical-trial/ 2024-04-30T09:51:22+00:00 https://legacy.arianapharma.com/esmo-2023-esmo-2023-advances-in-the-fight-against-cancer-through-artificial-intelligence/ 2024-03-06T14:07:04+00:00 https://legacy.arianapharma.com/cy6463-administration-is-linked-to-improvements-in-alzheimers-disease-relevant-biomarkers-as-revealed-by-explainable-ai-driven-analysis-of-multiple-phase-1-clinical-trials-%e2%80%8b/ 2023-03-29T13:26:08+00:00 https://legacy.arianapharma.com/ariana-pharma-strengthens-management-team-with-appointments-of-vp-business-development-and-chief-financial-officer/ 2023-03-24T16:52:55+00:00 https://legacy.arianapharma.com/wp-content/uploads/2022/02/CFO-Bertand-Lellouche-scaled-e1644317673604.jpg https://legacy.arianapharma.com/wp-content/uploads/2022/04/Marion-Soto.png https://legacy.arianapharma.com/anavex-ad-pd-2022-international-conference/ 2022-11-30T09:41:48+00:00 https://legacy.arianapharma.com/ariana-pharma-omicure-and-centre-leon-berard-clb-comprehensive-cancer-center-announce-strategic-collaboration-to-implement-ai-driven-precision-medicine-for-cancer-patients/ 2022-06-15T16:21:18+00:00 https://legacy.arianapharma.com/cyclerion-therapeutics-and-ariana-pharma-announce-an-artificial-intelligence-driven-precision-medicine-collaboration/ 2022-03-30T08:30:55+00:00 https://legacy.arianapharma.com/ariana-announces-appointment-of-accomplished-business-and-strategy-executive/ 2022-02-25T13:15:57+00:00 https://legacy.arianapharma.com/ariana-announces-an-artificial-intelligence-driven-precision-medicine-collaboration-with-sanofi/ 2022-02-25T13:15:48+00:00 https://legacy.arianapharma.com/ariana-appoints-pharmaceutical-industry-drug-development-veteran/ 2022-02-25T13:15:36+00:00 https://legacy.arianapharma.com/comorbidities-play-an-important-role-in-hospitalized-influenza-mortality-risk-real-world-evidence-rwe-study-performed-by-ariana-and-sanofi-pasteur-shows/ 2021-12-15T10:08:31+00:00 https://legacy.arianapharma.com/pharmaboardroom-interview-with-mohammad-afshar/ 2021-12-14T21:27:33+00:00 https://legacy.arianapharma.com/applying-the-cancer-playbook-to-find-treatment-for-alzheimers-disease/ 2021-12-14T21:24:55+00:00 https://legacy.arianapharma.com/artificial-intelligence-enables-first-biomarker-driven-precision-medicine-therapy-against-alzheimer/ 2021-12-14T21:24:00+00:00 https://legacy.arianapharma.com/arianas-ai-provides-evidence-for-3-years-clinical-efficacy-of-anavex2-73-alzheimers-targeted-therapy-ctad2018/ 2021-12-14T21:23:04+00:00 https://legacy.arianapharma.com/appointment-of-federico-goodsaid-phd-to-the-position-of-senior-vice-president-for-regulatory-affairs/ 2021-12-14T21:22:12+00:00 https://legacy.arianapharma.com/alzheimers-disease-dementia-early-detection-and-precision-medicine-using-kem-artificial-intelligence-ai-latest-research-results-presented-by-ariana-at-the-aaic-2019/ 2021-12-14T21:21:36+00:00 https://legacy.arianapharma.com/towards-a-first-precision-medicine-immunotherapy-for-the-treatment-of-type-1-diabetes-using-arianas-artificial-intelligence/ 2021-12-14T21:20:49+00:00 https://legacy.arianapharma.com/towards-a-first-precision-medicine-treatment-of-alzheimers-disease-using-arianas-explainable-ai/ 2021-12-14T21:18:29+00:00 https://legacy.arianapharma.com/ariana-pharma-announces-extemponmr-a-new-partnership-with-the-potential-to-revolutionize-brain-cancer-surgery/ 2021-12-14T19:04:45+00:00 https://legacy.arianapharma.com/ddn-news-interview-off-to-the-data-mines/ 2021-12-14T19:04:45+00:00 https://legacy.arianapharma.com/ep-vantage-interview-arianas-algorithms-could-deliver-bespoke-cancer-therapy/ 2021-12-14T19:04:45+00:00 https://legacy.arianapharma.com/les-echos-innovateurs-bio-informatique-la-fda-choisit-le-francais-ariana-pharma/ 2021-12-14T19:04:44+00:00 https://legacy.arianapharma.com/effective-design-of-multi-marker-diagnostic-tests-for-personalized-medicine/ 2021-12-14T19:04:44+00:00 https://legacy.arianapharma.com/biopharmanalyses-interview-ariana-pharma-trois-nouveaux-projets-lances-en-2013-pour-des-solutions-personnalisees-contre-le-cancer/ 2021-12-14T19:04:44+00:00 https://legacy.arianapharma.com/biotech-finances-audio-interview-ariana-pharma-selectionnee-par-deux-consortia-en-oncologie/ 2021-12-14T19:04:44+00:00 https://legacy.arianapharma.com/ariana-pharma-joins-the-win-consortium-as-official-technology-partner/ 2021-12-14T19:04:43+00:00 https://legacy.arianapharma.com/eacr-23-shorter-multimarker-signatures-a-new-tool-to-facilitate-cancer-diagnosis/ 2021-12-14T19:04:43+00:00 https://legacy.arianapharma.com/presentations-from-win-2014-symposium-paris-june-23-24/ 2021-12-14T19:04:43+00:00 https://legacy.arianapharma.com/onco-kemr-platform-for-personalized-cancer-treatment-selection/ 2021-12-14T19:04:18+00:00 https://legacy.arianapharma.com/colloque-scientifique-annuel-du-technion-paris-december-15/ 2021-12-14T19:04:18+00:00 https://legacy.arianapharma.com/gen-corporate-profile-arianas-analytics-aim-at-predictive-power/ 2021-12-14T19:04:18+00:00 https://legacy.arianapharma.com/nabsys-and-ariana-pharma-collaborate-to-identify-dna-structural-variants-linked-to-targeted-cancers/ 2021-12-14T19:04:17+00:00 https://legacy.arianapharma.com/nofinishline-paris-2016-paris-april-13/ 2021-12-14T19:04:17+00:00 https://legacy.arianapharma.com/win-2015-symposium-paris-29-30-june/ 2021-12-14T19:04:17+00:00 https://legacy.arianapharma.com/ariana-pharma-teams-together-with-sib-swiss-institute-of-bioinformatics-to-discover-novel-biomarkers-for-gastric-cancer/ 2021-12-14T19:04:17+00:00 https://legacy.arianapharma.com/win-2016-symposium-paris-june-27-28/ 2021-12-14T19:04:16+00:00 https://legacy.arianapharma.com/is-the-efficacy-of-milnacipran-in-fibromyalgia-predictable-a-data-mining-analysis-of-baseline-and-outcome-variables/ 2021-12-14T19:04:16+00:00 https://legacy.arianapharma.com/ariana-science-day-paris-may-9/ 2021-12-14T19:04:16+00:00 https://legacy.arianapharma.com/ariana-to-showcase-real-world-evidence-platform-at-astmh-2016-atlanta-usa-nov-13-17/ 2021-12-14T19:04:15+00:00 https://legacy.arianapharma.com/anavex-and-ariana-pharma-collaborate-to-accelerate-timelines-and-improve-efficiency-of-alzheimers-and-parkinsons-clinical-development-programs/ 2021-12-14T19:04:15+00:00 https://legacy.arianapharma.com/ariana-pharma-paris-boston-and-valiseek-london-to-collaborate-on-phase-ii-non-small-cell-lung-cancer-treatment/ 2021-12-14T19:04:15+00:00 https://legacy.arianapharma.com/ariana-pharma-joins-the-healthcare-data-institute/ 2021-12-14T19:04:15+00:00 https://legacy.arianapharma.com/api-2017-panama-may-16-20/ 2021-12-14T19:04:14+00:00 https://legacy.arianapharma.com/broadening-the-reach-of-precision-medicine-beyond-dna/ 2021-12-14T19:04:14+00:00 https://legacy.arianapharma.com/ariana-to-present-on-combination-therapy-in-melanoma-with-harvard-medical-school-paris-nov-29-dec-2nd/ 2021-12-14T19:04:14+00:00 https://legacy.arianapharma.com/win-2017-paris-jun-26-27/ 2021-12-14T19:04:13+00:00 https://legacy.arianapharma.com/ariana-pharma-finalist-in-eu-ehealth-2017-with-onco-kem/ 2021-12-14T19:04:13+00:00 https://legacy.arianapharma.com/arianas-kem-analysis-shows-positive-impact-on-patient-quality-of-life-for-valiseek-val401-in-phase-ii-trial-for-nsclc-patients/ 2021-12-14T19:03:47+00:00 https://legacy.arianapharma.com/arianas-kem-data-analysis-shows-positive-results-for-valiseek-val401-in-phase-ii-trial-for-non-small-cell-lung-cancer-nsclc-patients/ 2021-12-14T19:03:47+00:00 https://legacy.arianapharma.com/ctad-2017-boston-usa-1-4-nov/ 2021-12-14T19:03:47+00:00 https://legacy.arianapharma.com/anavex-incorporating-arianas-kem-ai-platform-in-alzheimers-precision-medicine-approach/ 2021-12-14T19:03:47+00:00 https://legacy.arianapharma.com/recombio-and-ariana-pharma-identify-lung-cancer-patients-most-benefiting-from-racotumomab-vaccine-therapy/ 2021-12-14T19:03:46+00:00 https://legacy.arianapharma.com/autism-and-automatic-analysis-of-hand-movements/ 2021-12-14T19:03:46+00:00